New Cancer Treatment Advances to Phase 2 Trials

1 min read
Source: statnews.com
New Cancer Treatment Advances to Phase 2 Trials
Photo: statnews.com
TL;DR

Researchers are showing promising progress in treating small cell lung cancer with a new immunotherapy targeting PDL1 and VEGF, demonstrating significant tumor reduction in a Phase 2 trial, which could mark a breakthrough in difficult cancer treatments.

Share this article

Want the full story? Read the original reporting

Read on statnews.com